Janssen-Cilag International NV has announced results from the phase 3 MARIPOSA study, demonstrating a significant overall survival benefit for patients with EGFR-mutated advanced non-small cell lung ...

Despite the mooted private sector investment, the minister says rail lines and ports will remain under state ownership.

Only liberal America could be more upset over an encrypted messenger app slip-up than a shambolic exit from Afghanistan that got Americans killed. Democrats think they smell blood in the water, as ...

Archbishop Anthony Fisher of Sydney this week credited the apparently miraculous survival of an Arizona toddler to the intercession of Cardinal George Pell. According to the newspaper The ...

CAN-2409 extended median overall survival to 24.5 months in NSCLC patients, surpassing standard docetaxel chemotherapy outcomes. The treatment showed a significant survival benefit in non-squamous ...

Travis Gettys is a senior editor for Raw Story based in northern Kentucky. He previously worked as a web editor for WLWT-TV and a contributing writer for the Kentucky Enquirer, and he also wrote ...

In an interesting and unusual item in Cabometyx’s updated label, the FDA acknowledges the potential impact that control arm patient crossovers may have had on Cabometyx’s patient survival ...

While the median overall survival time was not yet reached for the combo, investigators expect that the J&J regimen could offer at least an extra year of life versus Tagrisso, on which patients ...